Literature DB >> 9820498

Tolerant CD8 T cells induced by multiple injections of peptide antigen show impaired TCR signaling and altered proliferative responses in vitro and in vivo.

P M Dubois1, M Pihlgren, M Tomkowiak, M Van Mechelen, J Marvel.   

Abstract

The mechanisms responsible for peripheral CD8 T cell tolerance to foreign Ags remain poorly understood. In this study we have characterized the state of CD8 T cell tolerance induced in F5 TCR transgenic mice by multiple peptide injections in vivo. The tolerant state of CD8 T cells is characterized by impaired proliferative responses, increased sensitivity to cell death, and failure to acquire cytotoxic effector function after in vitro antigenic challenge. In vivo monitoring of CD8 T cell proliferation using 5-carboxyfluorescein diacetate succinimidyl ester showed that a large subset of the tolerant T cell population failed to divide in response to peptide. TCR down-regulation could not account for this loss of responsiveness to Ag since recombination-activating gene-1 (RAG-1)-/-F5 CD8 T cell responses were similar to those of RAG-1(-/-)F5 x RAG-1(-/-)F1 T lymphocytes, which express lower levels of the transgenic TCR. Analysis of early signal transduction in tolerant CD8 T cells revealed high basal levels of cytoplasmic calcium as well as impaired calcium mobilization and tyrosine phosphorylation after cross-linking of CD3epsilon and CD8alpha. Together these data indicate that repeated exposure to soluble antigenic peptide in vivo can induce a state of functional tolerance characterized by defective TCR signaling, impaired proliferation, and increased sensitivity to cell death.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9820498

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Expansion of activated human naïve T-cells precedes effector function.

Authors:  J M Brenchley; D C Douek; D R Ambrozak; M Chatterji; M R Betts; L S Davis; R A Koup
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

2.  Antigen-specific dose-dependent system for the study of an inheritable and reversible phenotype in mouse CD4+ T cells.

Authors:  Eduardo J Firpo; Raymond K Kong; Qinghong Zhou; Alexander Y Rudensky; James M Roberts; B Robert Franza
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

3.  Activation-threshold tuning in an affinity model for the T-cell repertoire.

Authors:  Almut Scherer; André Noest; Rob J de Boer
Journal:  Proc Biol Sci       Date:  2004-03-22       Impact factor: 5.349

4.  Foxp3+ regulatory T cells impede the priming of protective CD8+ T cells.

Authors:  James M Ertelt; Jared H Rowe; Margaret A Mysz; Charanjeet Singh; Monika Roychowdhury; Marijo N Aguilera; Sing Sing Way
Journal:  J Immunol       Date:  2011-08-01       Impact factor: 5.422

5.  Pivotal Advance: Nonfunctional lung effectors exhibit decreased calcium mobilization associated with reduced expression of ORAI1.

Authors:  Subhashini Arimilli; Sharad K Sharma; Rama Yammani; Sean D Reid; Griffith D Parks; Martha A Alexander-Miller
Journal:  J Leukoc Biol       Date:  2010-01-26       Impact factor: 4.962

Review 6.  Self-tolerance and the composition of T cell repertoire.

Authors:  L A Sherman; D J Morgan; C T Nugent; F J Hernandez; H T Kreuwel; A Murtaza; A Ko; J Biggs
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

7.  Anergic CD8+ T lymphocytes have impaired NF-κB activation with defects in p65 phosphorylation and acetylation.

Authors:  Paúl E Clavijo; Kenneth A Frauwirth
Journal:  J Immunol       Date:  2011-12-28       Impact factor: 5.422

8.  Soluble peptide treatment reverses CD8 T-cell-induced disease in a mouse model of spontaneous tissue-selective autoimmunity.

Authors:  So Yeon Paek; Fumi Miyagawa; Hong Zhang; Jay T Linton; Shelley B Hoover; R Mark Simpson; Stephen I Katz
Journal:  J Invest Dermatol       Date:  2011-11-17       Impact factor: 8.551

Review 9.  Molecular regulation of T-cell anergy.

Authors:  Yan Zheng; Yuanyuan Zha; Thomas F Gajewski
Journal:  EMBO Rep       Date:  2008-01       Impact factor: 8.807

10.  CD8(+) T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function.

Authors:  Claes Ohlén; Michael Kalos; Laurence E Cheng; Aaron C Shur; Doley J Hong; Bryan D Carson; Niels C T Kokot; Cara G Lerner; Blythe D Sather; Eric S Huseby; Philip D Greenberg
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.